Skip to main content
. Author manuscript; available in PMC: 2014 Oct 2.
Published in final edited form as: Cancer. 2012 Jun 15;118(23):5811–5818. doi: 10.1002/cncr.27623

Fig 1.

Fig 1

Fig 1

Fig 1

(A) Cumulative relative survival of all patients with acute promyelocytic leukemia by calendar period of diagnosis (SEER). (B) Overall survival of patients with acute promyelocytic leukemia by treatment era (MD Anderson Cancer Center). (C) Event-free survival of patients with acute promyelocytic leukemia by treatment era (MD Anderson Cancer Center). AIDA, all-trans retinoic acid plus idarubicin; ATRA, all-trans retinoic acid; GO, gemtuzumab ozogamicin.